Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Futoshi Nagashima
Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients With Septic Shock
Journal of Nippon Medical School
Medicine
Related publications
Re-Evaluation of Direct Hemoperfusion With Polymyxin-B Immobilized Fiber for Severe Sepsis and Septic Shock
Critical Care
Critical Care
Intensive Care Medicine
Polymyxin B Hemoperfusion in High Endotoxin Activity Level Septic Shock Patients
Critical Care
Critical Care
Intensive Care Medicine
Improved Outcome of Septic Shock Patients Treated Without Polymyxin B Hemoperfusion
Nihon Kyukyu Igakukai Zasshi
Correction To: Polymyxin B-Immobilized Hemoperfusion and Mortality in Critically Ill Adult Patients With Sepsis/Septic Shock: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Intensive Care Medicine
Critical Care
Intensive Care Medicine
The Role of Plasminogen Activator Inhibitor 1 Measurement With Endotoxin Adsorption Therapy (PMX-DHP) for Postoperative Septic Shock Patients
Critical Care
Critical Care
Intensive Care Medicine
A Case of Successful Treatment With Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion in Acute Respiratory Distress Syndrome After Influenza a Infection
Internal Medicine
Internal Medicine
Medicine
Ceramide; Sphingosine 1-Phosphate (S1P)
Science-Business eXchange
Continuous Hemodiafiltration With Polymyxin-B Immobilized Fiber Is Effective in Patients With Sepsis Syndrome and Acute Renal Failure
Therapeutic Apheresis and Dialysis
Hematology
Nephrology
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
